Hospital-acquired Infection Control Market Overview
As per MRFR analysis, the Hospital-acquired Infection Control Market Size was estimated at 14.43 (USD Billion) in 2022. The Hospital-acquired Infection Control Market Industry is expected to grow from 15.56 (USD Billion) in 2023 to 30.73 (USD Billion) by 2032. The Hospital-acquired Infection Control Market CAGR (growth rate) is expected to be around 7.85% during the forecast period (2024 - 2032).
Key Hospital-acquired Infection Control Market Trends Highlighted
Key market drivers for Hospital-acquired Infection Control include increasing healthcare-associated infections, growing awareness of infection prevention practices, and stringent government regulations.
Opportunities lie in the development of innovative technologies, such as antimicrobial surfaces, and the expansion of infection control programs in developing countries.
Recent trends show a rise in the use of artificial intelligence (AI) and machine learning (ML) for infection surveillance and predictive modeling.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Hospital-acquired Infection Control Market Drivers
Growing Prevalence of Healthcare-Associated Infections (HAIs)
Healthcare-associated infections (HAIs) are a major health concern, affecting millions of patients each year. HAIs are infections that are acquired during the course of receiving medical care, and they can range from minor skin infections to life-threatening sepsis.
The growing prevalence of HAIs is a major driver of the Hospital-acquired Infection control market. As the number of HAIs increases, so does the need for effective infection control measures.
This is driving demand for a wide range of infection control products and services, including disinfectants, personal protective equipment (PPE), and surveillance systems. The rising prevalence of HAIs is due to a number of factors, including the increasing use of invasive medical procedures, the growing number of immunocompromised patients, and the emergence of new and more resistant pathogens.
HAIs are a particular problem in hospitals, where patients are often more vulnerable to infection due to their weakened immune systems. The economic burden of HAIs is also a major driver of the Hospital-acquired Infection control market.
HAIs can lead to longer hospital stays, increased healthcare costs, and even death. In the United States, HAIs are estimated to cost the healthcare system billions of dollars each year. The growing prevalence of HAIs, the increasing economic burden of HAIs, and the need for effective infection control measures are all driving the growth of the Hospital-acquired Infection control market.
This market is expected to continue to grow in the coming years as the healthcare industry focuses on improving patient safety and reducing the incidence of HAIs. Some of the key players in the Hospital-acquired Infection control market include 3M, BD, Cardinal Health, Ecolab, and Getinge.
These companies offer a wide range of infection control products and services, including disinfectants, PPE, and surveillance systems. The Hospital-acquired Infection control market is a complex and dynamic market. The market is driven by a number of factors, including the growing prevalence of HAIs, the increasing economic burden of HAIs, and the need for effective infection control measures.
The market is expected to continue to grow in the coming years as the healthcare industry focuses on improving patient safety and reducing the incidence of HAIs.
Increasing Adoption of Advanced Infection Control Technologies
The increasing adoption of advanced infection control technologies is another major driver of the Hospital-acquired Infection control market. These technologies include automated hand hygiene dispensers, UV disinfection systems, and rapid diagnostic tests.
These technologies are helping to improve infection control practices and reduce the incidence of HAIs. Automated hand hygiene dispensers are touchless dispensers that dispense soap or sanitizer without the need for the user to touch the dispenser.
This helps to reduce the spread of bacteria and viruses, as users do not have to touch a potentially contaminated surface. UV disinfection systems use ultraviolet light to kill bacteria and viruses. These systems can be used to disinfect surfaces, equipment, and even the air.
UV disinfection systems are becoming increasingly popular in healthcare settings, as they are effective in killing a wide range of pathogens. Rapid diagnostic tests can quickly and accurately identify the presence of bacteria or viruses.
This information can help clinicians to make faster and more informed decisions about patient care. Rapid diagnostic tests are also helping to reduce the use of antibiotics, as they can identify infections that do not require antibiotic treatment.
The increasing adoption of advanced infection control technologies is helping to improve infection control practices and reduce the incidence of HAIs. This is a major driver of the Hospital-acquired Infection control market, and it is expected to continue to drive growth in the coming years.
Government Regulations and Initiatives
Government regulations and initiatives are also playing a role in driving the growth of the Hospital-acquired Infection control market. Many governments have implemented regulations that require hospitals to adopt certain infection control measures.
These regulations are helping to improve infection control practices and reduce the incidence of HAIs. In addition, many governments are providing funding for infection control research and development.
This funding is helping to drive the development of new and innovative infection control products and services. Government regulations and initiatives are helping to create a more favorable environment for the growth of the Hospital-acquired Infection control market.
These regulations and initiatives are helping to improve infection control practices, reduce the incidence of HAIs, and drive the development of new and innovative infection control products and services.
Hospital-acquired Infection Control Market Segment Insights
Hospital-acquired Infection Control Market Type of Infection Insights
The Hospital-acquired Infection Control Market is expected to witness robust growth in the coming years, driven by the increasing prevalence of healthcare-associated infections (HAIs). HAIs are a major public health concern, affecting millions of patients worldwide and leading to significant morbidity and mortality.
The market for Hospital-acquired Infection Control is segmented into various categories, including type of infection, end-user, and region. Based on the type of infection, the market is segmented into surgical site infections, catheter-associated urinary tract infections, pneumonia, Clostridioides difficile infection, and central line-associated bloodstream infections.
Surgical Site Infections (SSIs) Surgical Site Infections (SSIs) are the most common type of HAI, accounting for approximately 30% of all HAIs. SSIs can occur at the site of any surgical incision and can range in severity from minor skin infections to life-threatening deep tissue infections.
The market for SSI control is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 7.5%. Catheter-Associated Urinary Tract Infections (CAUTIs) Catheter-Associated Urinary Tract Infections (CAUTIs) are the second most common type of HAI, accounting for approximately 20% of all HAIs.
CAUTIs are caused by bacteria that enter the urinary tract through a catheter, which is a tube inserted into the bladder to drain urine. The market for CAUTI control is expected to reach USD 2.8 billion by 2024, growing at a CAGR of 6.8%.
Pneumonia Pneumonia is a lung infection that can be caused by bacteria, viruses, or fungi. Pneumonia is a leading cause of death in hospitals, accounting for approximately 10% of all HAIs. The market for pneumonia control is expected to reach USD 3.2 billion by 2024, growing at a CAGR of 7.2%. Clostridioides difficile Infection (CDI) Clostridioides difficile Infection (CDI) is a bacterial infection that causes severe diarrhea.
CDI is a common HAI, affecting approximately 5% of hospitalized patients. The market for CDI control is expected to reach USD 1.5 billion by 2024, growing at a CAGR of 6.5%.
Central Line-Associated Bloodstream Infections (CLABSIs) Central Line-Associated Bloodstream Infections (CLABSIs) are bloodstream infections that are caused by bacteria that enter the bloodstream through a central line, which is a tube inserted into a large vein in the chest or neck.
CLABSIs are serious HAIs with a mortality rate of up to 25%. The market for CLABSI control is expected to reach USD 1.2 billion by 2024, growing at a CAGR of 6.3%.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Hospital-acquired Infection Control Market Pathogen Type Insights
The Hospital-acquired Infection Control Market segmentation by Pathogen Type includes Bacteria, Viruses, Fungi, and Parasites. Among these, Bacteria held the dominant market share in 2023 and is expected to maintain its dominance throughout the forecast period.
The high prevalence of bacterial infections in hospitals, such as MRSA and C. difficile, is a major factor driving the growth of this segment. Viruses are also a significant segment, with increasing incidences of viral infections such as influenza and norovirus in healthcare settings.
Fungi and parasites account for a smaller share of the market but are still important contributors to hospital-acquired infections. The increasing focus on infection prevention and control measures is expected to drive the growth of the Hospital-acquired Infection Control Market over the forecast period.
Hospital-acquired Infection Control Market Control Measure Insights
The Control Measure segment of the Hospital-acquired Infection Control Market is anticipated to exhibit robust growth, driven by increasing awareness about healthcare-associated infections (HAIs) and the adoption of advanced infection control practices.
Antibiotics, antiseptics, and disinfectants remain the mainstay of infection control, with the antibiotics market projected to reach USD 55.9 billion by 2024. Antiseptics and disinfectants are also expected to witness significant demand, owing to their efficacy in preventing the spread of HAIs.
Isolation, including the use of negative pressure rooms and cohorts, is another key control measure. Vaccination plays a crucial role in preventing HAIs, with vaccines available for diseases such as influenza, measles, and hepatitis B.
The Hospital-acquired Infection Control Market is expected to witness substantial growth in the coming years, driven by rising healthcare expenditure, technological advancements, and increasing demand for effective infection control solutions.
Hospital-acquired Infection Control Market End User Insights
The Hospital-acquired Infection Control Market is segmented by End User into Hospitals, Clinics, Long-Term Care Facilities, and Ambulatory Surgical Centers. Hospitals hold the largest market share due to the high prevalence of HAIs in these settings.
The increasing number of surgical procedures, longer hospital stays, and the presence of vulnerable patients contribute to the high demand for infection control measures in hospitals. Clinics are expected to witness significant growth over the forecast period due to the rising number of outpatient procedures and the growing emphasis on infection prevention in ambulatory settings.
Long-Term Care Facilities are anticipated to experience steady growth due to the increasing number of elderly patients and the rising prevalence of chronic diseases that require long-term care. Ambulatory Surgical Centers are expected to witness moderate growth as they offer a cost-effective and convenient alternative to traditional hospital settings for certain surgical procedures.
Hospital-acquired Infection Control Market Technology Insights
The Hospital-acquired Infection Control Market is segmented by technology into Ultraviolet Light Disinfection, Negative Pressure Isolation, Automated Hand Hygiene Dispensers, Antimicrobial Coatings, and Point-of-Care Diagnostics.
The Ultraviolet Light Disinfection segment held the largest market share in 2023, owing to its increasing adoption in hospitals to reduce the risk of HAIs. The Negative Pressure Isolation segment is also expected to witness significant growth, driven by the rising demand for isolation rooms to prevent the spread of airborne infections.
Automated Hand Hygiene Dispensers are gaining popularity due to their ability to promote hand hygiene compliance among healthcare workers. Antimicrobial Coatings are being increasingly used to prevent the growth of microorganisms on hospital surfaces, while Point-of-Care Diagnostics are being adopted to enable rapid and accurate diagnosis of HAIs.
Hospital-acquired Infection Control Market Regional Insights
The Hospital-acquired Infection Control Market is segmented into regions comprising 'North America', 'Europe', 'APAC', 'South America', and 'MEA'. Regionally, North America is expected to hold the largest market share with an expected valuation of 10.25 billion USD by 2024.
The region's market growth is attributed to the increasing prevalence of hospital-acquired infections (HAIs), stringent government regulations related to infection control, and the presence of advanced healthcare infrastructure.
Europe is anticipated to follow North America with the second-largest market share of 6.1 Billion USD in 2024 due to factors such as rising healthcare expenditure, growing awareness of HAIs, and the adoption of advanced technologies for infection control.
APAC is projected to experience significant market growth at a CAGR of 8.25% during the forecast period, owing to the increasing number of hospitals, rising patient population, and expanding healthcare facilities in the region.
South America and MEA are expected to witness steady growth in the Hospital-acquired Infection Control Market, with a focus on strengthening infection control practices and improving patient safety.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Hospital-acquired Infection Control Market Key Players and Competitive Insights
Major players in the Hospital-acquired Infection Control Market industry are focusing on developing innovative products and solutions to meet the evolving needs of the market. Leading Hospital-acquired Infection Control Market players are investing in research and development to enhance the efficacy and safety of their products.
The Hospital-acquired Infection Control Market's development of new technologies, such as antimicrobial coatings and rapid diagnostic tests, is driving the growth of the market. Merger and acquisition activities are also prevalent in the Hospital-acquired Infection Control Market Competitive Landscape, as companies seek to expand their product portfolios.
Stryker is one of the prominent players in the Hospital-acquired Infection Control Market. The company offers a comprehensive range of products and services for infection prevention and control, including surgical instruments, surgical gowns, and disinfectants.
Stryker's commitment to innovation has led to the development of several cutting-edge technologies, such as the SurgiCount+ Surgical Sponge System and the Neptune Washer-Disinfector. These technologies have been designed to improve patient safety and reduce the risk of infections.
3M is another leading company in the Hospital-acquired Infection Control Market. The company offers a wide range of products for infection prevention and control, including hand hygiene products, disinfectants, and surgical drapes.
3M's focus on research and development has resulted in the development of innovative products, such as the Steri-Drape and Steri-Strip products. These products have been designed to improve patient safety and reduce the risk of infections.
Key Companies in the Hospital-acquired Infection Control Market Include
- BD
- Medtronic
- Sterigenics
- Baxter International
- Steris
- Getinge
- Kimberly-Clark
- Ecolab
- Johnson Johnson
- Cardinal Health
- Sotera Health
- Stryker
- 3M
Hospital-acquired Infection Control Market Industry Developments
The market growth is attributed to the rising prevalence of hospital-acquired infections (HAIs), increasing awareness about infection prevention and control measures, and technological advancements in infection control products and devices.
Recent developments in the market include the launch of innovative products such as antimicrobial coatings, UV disinfection systems, and AI-powered infection surveillance solutions.
Key players in the market are focusing on strategic collaborations and acquisitions to expand their product portfolios and geographical reach. Government initiatives and regulations aimed at reducing HAIs are also driving market growth.
Hospital-acquired Infection Control Market Segmentation Insights
Hospital-acquired Infection Control Market Type of Infection Outlook
Surgical Site Infections
Catheter-Associated Urinary Tract Infections
Pneumonia
Clostridioides difficile Infection
Central Line-Associated Bloodstream Infections
Hospital-acquired Infection Control Market Pathogen Type Outlook
Bacteria
Viruses
Fungi
Parasites
Hospital-acquired Infection Control Market Control Measure Outlook
Antibiotics
Antiseptics
Disinfectants
Isolation
Vaccination
Hospital-acquired Infection Control Market End User Outlook
Hospitals
Clinics
Long-Term Care Facilities
Ambulatory Surgical Centers
Hospital-acquired Infection Control Market Technology Outlook
Ultraviolet Light Disinfection
Negative Pressure Isolation
Automated Hand Hygiene Dispensers
Antimicrobial Coatings
Point-of-Care Diagnostics
Hospital-acquired Infection Control Market Regional Outlook
North America
Europe
South America
Asia Pacific
Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
14.43(USD Billion) |
| Market Size 2023 |
15.56(USD Billion) |
| Market Size 2032 |
30.73(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
7.85% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
BD, Medtronic, Sterigenics, Baxter International, Steris, Getinge, Kimberly-Clark, Ecolab, Johnson Johnson, Cardinal Health, Sotera Health, Stryker, 3M |
| Segments Covered |
Type of Infection, Pathogen Type, Control Measure, End User, Technology, Regional |
| Key Market Opportunities |
1 Growing incidence of hospital-acquired infections HAIs 2 Rising awareness of HAIs and their consequences 3 Technological advancements in infection control products 4 Increasing focus on patient safety and quality of care 5 Favorable regulatory landscape |
| Key Market Dynamics |
Increasing prevalence of HAIs Growing adoption of infection prevention technologies Strict regulatory guidelines Rising healthcare expenditure Advancements in diagnostics |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Hospital-acquired Infection Control Market is expected to reach USD 30.73 billion by 2032, growing at a CAGR of 7.85% from 2024 to 2032.
The key regions of the Hospital-acquired Infection Control Market are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The key applications of the Hospital-acquired Infection Control Market are surgical site infections, bloodstream infections, urinary tract infections, and respiratory infections.
The key competitors in the Hospital-acquired Infection Control Market are 3M, BD, Cardinal Health, Ecolab, Getinge, Johnson Johnson, Kimberly-Clark, Medtronic, and Stryker.
The Hospital-acquired Infection Control Market is expected to grow at a CAGR of 7.85% from 2024 to 2032.
The key factors driving the growth of the Hospital-acquired Infection Control Market are the increasing prevalence of hospital-acquired infections, rising demand for infection control products and services, and government initiatives to reduce healthcare-associated infections.
The key challenges facing the Hospital-acquired Infection Control Market are rising costs of infection control products and services, lack of awareness about infection control practices, and increasing antimicrobial resistance.
The key opportunities for the Hospital-acquired Infection Control Market are growing demand for innovative infection control solutions, rising adoption of advanced technologies, and expanding healthcare infrastructure in emerging markets.
The key trends in the Hospital-acquired Infection Control Market are increasing focus on infection prevention, adoption of digital technologies, and use of artificial intelligence (AI) in infection control.
The future outlook of the Hospital-acquired Infection Control Market is positive due to rising healthcare expenditure, increasing demand for infection control products and services, and government initiatives to reduce healthcare-associated infections.
